IQVIA director receives 172 deferred share units

IQVIA Holdings Inc. director John G. Danhakl received a grant of 172 deferred share units on February 9, 2026.

Accepted by SEC EDGAR 02/11/2026 - 05:05 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

IQVIA Holdings Inc. director John G. Danhakl received a grant of 172 deferred share units on February 9, 2026. The grant is valued at $192.67 per deferred share and increases his directly held deferred shares to 2,944.

Each deferred share converts into one share of IQVIA common stock upon settlement, which occurs under the company’s Non-Employee Director Deferral Plan when he ceases to be a director, upon a change in control of the company, or upon his death. The deferred shares have no expiration date.

Insider Trade Summary

Grant/Award: 172 shares

Grant/Award 1 txn

Insider DANHAKL JOHN G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Shares	172	$192.67	$33K

Holdings After Transaction: Deferred Shares — 2,944 contracts (Direct)

Footnotes (1)

1. F1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IQV (IQVIA Holdings Inc.) report for John G. Danhakl?

IQVIA reported that director John G. Danhakl received 172 deferred share units on February 9, 2026. These derivative awards are valued at $192.67 per unit and raise his directly held deferred share balance to 2,944, all convertible into common stock upon specified settlement events.

At what price were the 172 deferred shares granted to IQV director John G. Danhakl?

The 172 deferred share units granted to John G. Danhakl were valued at $192.67 per deferred share. This price applies to the derivative award reported and is used to calculate the grant’s notional value, though the deferred shares ultimately settle into IQVIA common stock on a one-for-one basis.

How many IQV deferred share units does John G. Danhakl hold after this Form 4 transaction?

After the February 9, 2026 grant, John G. Danhakl beneficially owns 2,944 deferred share units directly. Each deferred share is convertible into one IQVIA Holdings Inc. common share upon settlement, according to the company’s Non-Employee Director Deferral Plan terms described in the filing’s explanatory footnote.

When do the deferred shares granted to IQV director John G. Danhakl settle into common stock?

The deferred shares settle into IQVIA common stock when John G. Danhakl ceases to be a director, upon a change in control of the company, or upon his death. Settlement timing is governed by IQVIA’s Non-Employee Director Deferral Plan and the footnote states there is no expiry date.

What does each IQV deferred share granted to John G. Danhakl represent?

Each deferred share granted to John G. Danhakl represents the right to receive one share of IQVIA Holdings Inc. common stock upon settlement. These are derivative securities issued under the Non-Employee Director Deferral Plan, rather than immediate common shares, and have no stated expiration date in the disclosure.

Is the ownership of the deferred shares by John G. Danhakl in IQV direct or indirect?

The filing shows John G. Danhakl’s 2,944 deferred share units as directly owned, indicated by the ownership code “D”. No nature-of-ownership qualifier is listed, so the reported derivative securities are held in his direct capacity as a director participant in the Non-Employee Director Deferral Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DANHAKL JOHN G

(Last) (First) (Middle)

C/O IQVIA HOLDINGS INC.

2400 ELLIS ROAD

(Street)

DURHAM NC 27703

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Shares	(1)	02/09/2026		A		172		(1)	(1)	Common Stock	172	$192.67	2,944	D

Explanation of Responses:

1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Remarks:

	/s/ Matthew Gilmartin, Attorney-in-Fact for John G. Danhakl	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.